WebMay 31, 2024 · A trial of radiotherapy and targeted treatment for non small cell lung cancer (CONCORDE) Cancer type: Lung cancer Non small cell lung cancer Status: Open Phase: … WebMar 29, 2024 · The second meta-analysis of surgery plus radiotherapy and chemotherapy versus surgery plus radiotherapy was based on 13 trial comparisons and 2660 patients (1909 deaths). We recorded a benefit of adding chemotherapy to surgery plus radiotherapy (HR 0.88, 95% CI 0.81-0.97, p=0.009), representing an absolute improvement in survival of …
Radiotherapy improves the survival of patients with extensive …
Web17 Department of Radiation Oncology, Mount Sinai Medical Center, New York, NY. Electronic address: [email protected]. PMID: 32222430 DOI: 10.1016/j.prro.2024.02.009 Clinical Trial, Phase III Guideline Randomized Controlled Trial Female Humans Lung Neoplasms / pathology Lung Neoplasms / radiotherapy* Male WebImportance Stereotactic ablative radiotherapy (SABR) is a standard treatment option in patients with medically inoperable early-stage non–small cell lung cancer (NSCLC), yet the pathologic complete response (pCR) rate after SABR is unknown. Neoadjuvant SABR in patients with cancer who are fit for resection has been hypothesized to improve local … bitex hub spares
Oral vinorelbine and cisplatin with concurrent radiotherapy
WebDec 8, 2024 · The UK Phase 2 SOCCAR trial, which compared sequential versus concurrent chemotherapy and radical hypofractionated radiotherapy in 130 patients with unresectable stage III NSCLC and good ... WebPurpose: Several sentinel phase III randomized trials have recently been published challenging traditional radiation therapy (RT) practices for small cell lung cancer (SCLC). … WebThe randomised PEMBRO-RT phase 2 trial showed that stereotactic body radiotherapy delivered to a single tumour site enhanced the effect of pembrolizumab in non-irradiated lesions of metastatic NSCLC, but the results did not meet the preset endpoint criteria for meaningful clinical benefit. dass profile sheet